Molecular Data Inc. is a leading technology-driven platform in China's chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company's e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.
Company profile
Ticker
MKDTY
Exchange
Website
CEO
Zheng Wang
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
MKDTY stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
27 Oct 22
6-K
Molecular Data Receives De-Listing Notice from NASDAQ
27 May 22
6-K
Molecular Data Inc. Announces ADS Ratio Change
20 May 22
6-K
Molecular Data Inc. Announces Receipt of Nasdaq Non-Compliance Letter
19 May 22
F-6EF
Automatic registration for ADRs (foreign)
13 May 22
NT 20-F
Notice of late annual filing (foreign)
2 May 22
6-K
Current report (foreign)
30 Nov 21
6-K
Current report (foreign)
26 Nov 21
6-K
Current report (foreign)
1 Oct 21
6-K
Molecular Data Inc. Prices $15 Million Registered Direct Offering
17 Sep 21
Latest ownership filings
SC 13G
TB Alternative Assets Ltd.
5 Feb 24
SC 13G/A
Streeterville Capital LLC
5 Oct 23
SC 13G/A
TB Alternative Assets Ltd.
9 Feb 23
SC 13G
TB Alternative Assets Ltd.
8 Feb 23
SC 13G/A
Streeterville Capital LLC
17 Aug 22
SC 13G/A
SHEN NEIL NANPENG
14 Feb 22
SC 13G
TB Alternative Assets Ltd.
11 Feb 22
SC 13G
TB Alternative Assets Ltd.
11 Feb 22
SC 13G
Hudson Bay Capital Management LP
7 Feb 22
SC 13G
Innovation Works Development Fund II, L.P.
28 Apr 21
Financial summary
Quarter (USD) | Dec 20 | Dec 19 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q2 2022
44.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 6 |
Closed positions | 5 |
Increased positions | 2 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 68.03 mm |
Total shares | 73.23 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Innovation Works Development Fund II | 36.23 mm | $30.43 mm |
Streeterville Capital | 35.90 mm | $36.98 mm |
TB Alternative Assets | 749.80 k | $421.00 k |
Gsa Capital Partners | 66.05 k | $37.00 k |
Susquehanna International | 52.73 k | $30.00 k |
UBS UBS Group AG - Registered Shares | 45.51 k | $26.00 k |
VIRT Virtu Financial | 41.95 k | $24.00 k |
Citadel Advisors | 27.60 k | $15.00 k |
Geode Capital Management | 22.22 k | $12.00 k |
Envestnet Asset Management | 20.60 k | $12.00 k |